From October 1, 2023 to December 31, 2023, the company has repurchased 5,983,233 shares, representing 0.99% for $444.26 million. With this, the company has completed the repurchase of 18,921,321 shares, representing 3.09% for $1,450.43 million under the buyback announced on July 28, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
86.1 USD | -2.31% | -2.00% | +12.92% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.92% | 53.11B | |
+9.55% | 222B | |
+14.41% | 195B | |
+24.02% | 148B | |
+33.92% | 113B | |
+4.18% | 66.45B | |
+3.16% | 50.03B | |
-4.32% | 38.8B | |
-1.99% | 34.85B | |
+23.04% | 30.98B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Tranche Update on Edwards Lifesciences Corporation (NYSE: EW)'s Equity Buyback Plan announced on July 28, 2022.